Immune responses to COVID booster vaccination; results of an UK-wide clinical trial

Results published in The Lancet for the COV-BOOST study, which was supported by the NIHR Cambridge CRF

Com-COV 3 COVID-19 vaccine study calls on teenager volunteers in Cambridgeshire

Researchers running the University of Oxford-led Com-COV programme have started enrolling young people aged 12 to 16 years old to receive a second dose of a COVID-19 vaccine, including Cambridgeshire.

Positive phase 3 results reported in trial for new Covid-19 vaccine

A clinical trial supported by the NIHR Cambridge CRF for a new vaccine against COVID-19 has received positive Phase 3 results.

Professor Rebecca Fitzgerald awarded The Don Listwin award

Congratulations to researcher, Professor Rebecca Fitzgerald, who has received the Don Listwin Award for Outstanding Contribution to Cancer Early Detection.

Could a cancer drug be key to helping patients recover from a heart attack?

A stage 2 trial is underway in Cambridge to investigate whether a cancer drug could improve the recovery of heart attack patients, by targeting the immune system.

Creating a new diagnostic test for oesophageal cancer

It has been 20 years since Professor Rebecca Fitzgerald came up with the idea of the cytosponge. Find out how the new device was created and how the NIHR Cambridge CRF supported the early clinical trials.

Researchers eye up new gene therapy trial that could reverse hereditary blindness

Restoration of sight from a rare genetic mutation may now become a reality thanks to a prestigious award from the National Institute for Health Research (NIHR) and Moorfields Eye Charity.

Cambridge researchers win Croonian Medal and Lecture 2022

Congratulations to Cambridge researchers Professor Sir Stephen O’Rahilly and Professor Sadaf Farooqi, who have been awarded the Croonian Medal and Lecture 2022 from the Royal Society.

Red4Research

On 18th June, we asked our team to wear Red4Research to show their support and appreciation for all those participating, undertaking and supporting COVID-19 research.